A comparison of MRI tissue relaxometry and ROI methods used to determine regional brain iron concentrations in restless legs syndrome

Medical Devices: Evidence and Research

Volumn 8, Issue , 2015, Pages 341-350

  Moon, Hye Jin ^a   Chang, Yongmin ^b   Lee, Yeong Seon ^a   Song, Huijin ^b   Chang, Hyuk Won ^c   Ku, Jeonghun ^c   Allen, Richard P ^d   Earley, Christopher J ^d   Cho, Yong Won ^a  

^a Dongsan Medical Center   (South Korea)

^b Kyungpook National University   (South Korea)

^c Keimyung University   (South Korea)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Iron; Region of interest; Relaxometry; Restless legs syndrome; Substantia nigra

Indexed keywords

IMAGE SEGMENTATION; MAGNETIC RESONANCE IMAGING;

DETERMINATION METHODS; FREE INDUCTION DECAY; IRON CONCENTRATIONS; REGION OF INTEREST; REGIONS OF INTEREST; RELAXOMETRY; RESTLESS LEGS SYNDROME; SUBSTANTIA NIGRA;

IRON;

IRON;

ADULT; ARTICLE; BRAIN LEVEL; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLOBUS PALLIDUS; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; IRON BRAIN LEVEL; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PUTAMEN; RED NUCLEUS; REGION OF INTEREST METHOD; RELAXOMETRY; RESTLESS LEGS SYNDROME; SUBSTANTIA NIGRA; THREE DIMENSIONAL IMAGING;

EID: 84940474158     PISSN: None     EISSN: 11791470     Source Type: Journal    
DOI: 10.2147/MDER.S83629     Document Type: Article

References (43)

1. Brass SD, Chen NK, Mulkern RV, Bakshi R. Magnetic resonance imaging of iron deposition in neurological disorders. Top Magn Reson Imaging. 2006;17(1):31–40.
2. Kosta P, Argyropoulou MI, Markoula S, Konitsiotis S. MRI evaluation of the basal ganglia size and iron content in patients with Parkinson’s disease. J Neurol. 2006;253(1):26–32.
3. Argyropoulou MI, Astrakas L. MRI evaluation of tissue iron burden in patients with beta-thalassaemia major. Pediatr Radiol. 2007;37(12):1191–1200.
4. Earley CJ, B Barker P, Horska A, Allen RP. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome. Sleep Med. 2006;7(5):458–461.
5. Graham JM, Paley MN, Grunewald RA, Hoggard N, Griffiths PD. Brain iron deposition in Parkinson’s disease imaged using the PRIME magnetic resonance sequence. Brain. 2000;123:2423–2431.
6. Margariti PN, Astrakas LG, Tsouli SG, Hadjigeorgiou GM, Konitsiotis S, Argyropoulou MI. Investigation of unmedicated early onset restless legs syndrome by voxel-based morphometry, T2 relax­ometry, and functional MR imaging during the night-time hours. AJNR. 2012;33(4):667–672.
7. Hening WA. Restless Legs Syndrome. Philadelphia: Saunders/Elsevier; 2009.
8. Connor JR, Boyer PJ, Menzies SL, Dellinger B, Allen RP, Earley CJ. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003;61:304–309.
9. Connor JR, Wang XS, Patton SM, et al. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology. 2004;62(9):1563–1567.
10. Clardy SL, Wang X, Boyer PJ, Earley CJ, Allen RP, Connor JR. Is ferroportin-hepcidin signaling altered in restless legs syndrome? J Neurol Sci. 2006;247(2):173–179.
11. Snyder AM, Wang X, Patton SM, et al. Mitochondrial ferritin in the substantia nigra in restless legs syndrome. J Neuropathol Exp Neurol. 2009;68(11):1193–1199.
12. Connor JR, Ponnuru P, Lee BY, et al. Postmortem and imaging based analyses reveal CNS decreased myelination in restless legs syndrome. Sleep Med. 2011;12(6):614–619.
13. Connor JR, Ponnuru P, Wang XS, Patton SM, Allen RP, Earley CJ. Profile of altered brain iron acquisition in restless legs syndrome. Brain. 2011;134(Pt 4):959–968.
14. Schmidauer C, Sojer M, Seppi K, et al. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol. 2005;58(4):630–634.
15. Godau J, Schweitzer KJ, Liepelt I, Gerloff C, Berg D. Substantia nigra hypoechogenicity: definition and findings in restless legs syndrome. Mov Disord. 2007;22(2):187–192.
16. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measure­ment of brain iron in patients with restless legs syndrome. Neurology. 2001;56(2):263–265.
17. Astrakas LG, Konitsiotis S, Margariti P, Tsouli S, Tzarouhi L, Argyropoulou MI. T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome. Neurology. 2008;71(12):911–916.
18. Godau J, Klose U, Di Santo A, Schweitzer K, Berg D. Multiregional brain iron deficiency in restless legs syndrome. Mov Disord. 2008;23(8): 1184–1187.
19. Knake S, Heverhagen JT, Menzler K, Keil B, Oertel WH, Stiasny-Kolster K. Normal regional brain iron concentration in restless legs syndrome measured by MRI. Nat Sci Sleep. 2010;2:19–22.
20. Cho YW, Shin WC, Yun CH, et al. Epidemiology of restless legs syndrome in Korean adults. Sleep. 2008;31(2):219–223.
21. Hening WA, Allen RP, Washburn M, Lesage S, Earley CJ. Validation of the Hopkins telephone diagnostic interview for restless legs syndrome. Sleep Med. 2008;9(3):283–289.
22. Yang J, Kim D, Lee J, et al. The reliability and validity of the Korean versions of the international restless legs scale and the restless legs syndrome quality of life questionnaire. J Korean Neurol Assoc. 2010;28(4):263–269.
23. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4(2):121–132.
24. Cho YW, Lee MY, Yun CH, Shin WC, Hong SB, Kim JH. The reli­ability and validity of the Korean version of paradigm of questions for epidemiology studies of restless legs syndrome and the Johns Hopkins telephone diagnostic interview form for the restless legs syn­drome. Journal of the Korean Neurological Association. 2007;25(4):494–499.
25. Cho YW, Lee JH, Son HK, Lee SH, Shin C, Johns MW. The reliability and validity of the Korean version of the Epworth sleepiness scale. Sleep Breath. 2011;15(3):377–384.
26. Sohn SI, Kim do H, Lee MY, Cho YW. The reliability and validity of the Korean version of the Pittsburgh Sleep Quality Index. Sleep Breath. 2012;16(3):803–812.
27. Gelman N, Gorell JM, Barker PB, et al. MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology. 1999;210(3):759–767.
28. Cho Z-H. 7.0 Tesla MRI Brain Atlas: In Vivo Atlas with Cryomacrotome Correlation. New York: Springer; 2010.
29. House MJ, St Pierre TG, Kowdley KV, et al. Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmor­tem brain tissue from alzheimer’s disease patients. Magn Reson Med. 2007;57(1):172–180.
30. Langkammer C, Krebs N, Goessler W, et al. Quantitative MR imaging of brain iron: a postmortem validation study. Radiology. 2010;257(2):455–462.
31. Ordidge RJ, Gorell JM, Deniau JC, Knight RA, Helpern JA. Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Mag Reson Med. 1994;32(3):335–341.
32. Hardy PA, Gash D, Yokel R, Andersen A, Ai Y, Zhang Z. Correlation of R2 with total iron concentration in the brains of rhesus monkeys. J Magn Reson Imaging. 2005;21(2):118–127.
33. Hikita T, Abe K, Sakoda S, Tanaka H, Murase K, Fujita N. Determination of transverse relaxation rate for estimating iron deposits in central nervous system. Neurosci Res. 2005;51(1):67–71.
34. Gorell J, Ordidge R, Brown G, Deniau J, Buderer N, Helpern J. Increased iron-related MRI contrast in the substantia nigra in Parkinson’s disease. Neurology. 1995;45(6):1138–1143.
35. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging. 2005;23(1):1–25.
36. Bilgic B, Pfefferbaum A, Rohlfing T, Sullivan EV, Adalsteinsson E. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage. 2012;59(3): 2625–2635.
37. Zheng W, Nichol H, Liu S, Cheng Y-CN, Haacke EM. Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluo­rescence imaging. Neuroimage. 2013;78(0):68–74.
38. Haba-Rubio J, Staner L, Petiau C, Erb G, Schunck T, Macher JP. Restless legs syndrome and low brain iron levels in patients with haemochromatosis. J Neurol Neurosurg Psychiatry. 2005;76(7): 1009–1010.
39. Lee B-Y, Farace E, Vesek J, Wang J, Connor J, Yang Q. In vivo measure­ment of iron deficiency in restless legs syndrome (rls) with voxel-based R2 relaxometry. Proc Intl Soc Mag Reson Med. 2007;15: 2170.
40. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in rest­less legs syndrome. Neurology. 2000;54(8):1698–1700.
41. Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res. 2005;14(1):43–47.
42. Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain. 1999;122:1421–1436.
43. Blazejewska AI, Schwarz ST, Pitiot A, et al. Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI. Neurology. 2013;81(6):534–540.